Updated:
Aligo Technologies
Axelys is an organization that aims to valorize public research in Québec. It provides support for the transfer of innovations, the growth of businesses, and...
Aligo Technologies
Axelys is an organization that aims to valorize public research in Québec. It provides support for the transfer of innovations, the growth of businesses, and the creation of new jobs. Axelys also publishes reports and hosts events to promote innovation and entrepreneurship in the region.
General information
Firm type
Generalist
Year founded
2021
Location
Region
North America
Country
Canada
City
Quebec
Corporate office
Quebec, Canada
Principals
Paule De Blois
Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Aligo Technologies?
Paule De Blois is recorded as founder. Current decisions route through the Axelys successor entity.
How does Aligo Technologies source proprietary deal flow?
Deal flow arrives via consortium partners including adMare BioInnovations, MEDTEQ+ and CQDM.
Does Aligo Technologies participate in fund commitments or only direct deals?
Activity centers on direct co-investments and seed-stage financings with named partners.
What investment stages does Aligo Technologies typically target?
The firm targets seed, start-up and growth stages.
Where does the underlying wealth come from?
No public disclosure identifies the origin of capital deployed by Aligo Technologies or Axelys.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: